Iron Triangle Partners’s NEVRO CORP. NVRO Stock Holding History

Iron Triangle Partners’s Portfolio NVRO Stock Details NVRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-562,833	Closed	-$40.7M	–	35
2022 Q1	$40.7M	Buy	562,833 +140,573	+33%	+$10.1M	4.84%	6
2021 Q4	$34.2M	Buy	422,260 +18,836	+5%	+$1.89M	4.77%	7
2021 Q3	$47M	Buy	403,424 +120,804	+43%	+$15.8M	6.74%	4
2021 Q2	$46.9M	Buy	282,620 +102,620	+57%	+$16M	4.83%	9
2021 Q1	$25.1M	Buy	180,000 +11,239	+7%	+$1.83M	3.19%	16
2020 Q4	$29.2M	Buy	168,761 +8,761	+5%	+$1.42M	3.79%	12
2020 Q3	$22.3M	Buy	160,000 +9,515	+6%	+$1.27M	4.98%	8
2020 Q2	$18M	Buy	150,485 +10,485	+7%	+$1.24M	4.53%	10
2020 Q1	$14M	Buy	140,000 +50,667	+57%	+$6.09M	5.41%	4
2019 Q4	$10.5M	Buy	+89,333	New	+$8.85M	2.78%	18

Other funds holding NVRO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Iron Triangle Partners's NVRO Position: Q2 2022 in Review

Iron Triangle Partners sold out of NEVRO CORP. (NVRO) in Q2 2022, closing a stake of 562,833 shares — an estimated $40.7M sold.

Iron Triangle Partners first reported a position in NVRO in Q4 2019 and held it in 10 quarters. The position peaked at $47M in Q3 2021. 175 funds tracked by Wall St. Rank hold NVRO as of Q2 2022.

Iron Triangle Partners reported no remaining NEVRO CORP. position as of Q2 2022 after selling out during the quarter.
Iron Triangle Partners sold 562,833 NEVRO CORP. shares in Q2 2022, an estimated $40.7M.
Iron Triangle Partners first reported a position in NEVRO CORP. in Q4 2019 and held it in 10 quarters.
Iron Triangle Partners's NEVRO CORP. position peaked at $47M in Q3 2021.
175 funds tracked by Wall St. Rank held NEVRO CORP. as of Q2 2022.

Based on Iron Triangle Partners's 13F filing for Q2 2022, filed 15 Aug 2022.